Vivantis Technologies Sdn Bhd

31 Aug 2023

Vivantis is proud to announce the upcoming launch of M-MuLV Reverse Transcriptase III, the third generation of M-MuLV Reverse Transcriptase RNase H¯ which can perform highly efficient reverse transcription reactions at 37-55°C.

Features:

• Able to synthesize cDNA from 100bp to >12 kb
• Superior continuous synthesis ability
• Strong impurity tolerance